Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di S Regulatory News (MYXR)

  • There is currently no data for MYXR

Trading Update

4 Mar 2016 07:00

RNS Number : 0278R
MyCelx Technologies Corporation
04 March 2016
 

 

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)("MYCELX" or the "Company")

 

Contract and Trading Update

 

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces that is has agreed a fixed term, two year contract for water treatment with one of its existing customers in the Middle East for a total value of US$5 million over the life of the contract.

 

In light of the continued weakness in the oil and gas industry and associated services, MYCELX's customers increased their focus on their own cost management during the last year. The award of a fixed term contract demonstrates MYCELX's value proposition and reliable performance of its technology for companies in the petrochemical industry.

 

This contract underpins a proportion of the Company's sales revenue for 2016. However, in this challenging environment, the Company has reviewed the run rate for its installed customer base and currently estimates a conservative base-level recurring revenue for FY2016 of US$8 million. MYCELX has continued with its expense control measures and expects that the Company would be at least cash neutral from operations in 2016 at this level of revenue.

 

The Company is actively pursuing its advanced stage pipeline and large scale trials are ongoing. The budgets and schedules for many projects remain uncertain and the whole oil and gas industry is observing significant delays in capital expenditure. However, the award of any further project work would materially improve the Company's revenue expectations for FY 2016.

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, Interim CFO

 

 

Tel: +1 888 306 6843

RFC Ambrian Limited

Corporate Finance

Samantha Harrison

Jonathan Stephens

 

Corporate Broking

Jonathan Williams

Kim Eckhof

 

Tel: +44 20 3440 6800

Numis Securities Limited

Corporate Broking

James Black

Ben Stoop

 

Tel: +44 20 7260 1000

Bell Pottinger

Nick Lambert

Henry Lerwill

 

Tel: +44 20 3772 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKNDKCBKDANK
Date   Source Headline
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results
7th Aug 20139:29 amRNSBalance of respective lines of stock
10th Jun 20135:16 pmRNSChange of Main Office Address
3rd Jun 20133:19 pmRNSTotal Voting Rights
28th May 20135:02 pmRNSHolding(s) in Company
28th May 20132:54 pmRNSDirector/PDMR Shareholding
24th May 20138:52 amRNSHolding(s) in Company
14th May 20132:14 pmRNSResult of Annual Meeting
14th May 20137:00 amRNSOperational Update & Directorate Change
9th May 20137:00 amRNSExercise of Warrant
23rd Apr 201312:49 pmRNSApplication for Block Admission
19th Apr 20137:00 amRNSAnnual Financial Report/Directorate Change
15th Apr 20132:18 pmRNSHolding(s) in Company
26th Mar 20135:21 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNS2012 Preliminary Results
18th Feb 201312:09 pmRNSTransfer of MyCelx Shares between lines of stock
3rd Jan 20137:00 amRNSIssue of Equity/Total Voting Rights
12th Nov 20129:52 amRNSTransfer of MyCelx Shares between lines of stock
8th Oct 20124:11 pmRNSTransfer of MyCelx Shares between lines of stock
13th Sep 20127:00 amRNSAppointment of CFO and Board Director
30th Aug 20127:00 amRNSMyCelx Shares to be Traded on CREST
14th Aug 20127:01 amRNSWebcast interview with CEO
14th Aug 20127:00 amRNSHalf Year Results
8th Aug 20127:00 amRNSContract Win for US$2.35 Million
31st May 20127:00 amRNSRe Contract
10th May 201211:02 amRNSResult of Annual Meeting/Grant of Share Option
9th May 20127:00 amRNSTrading Statement
23rd Apr 20127:00 amRNSPurchase Orders Received for US$2.65 million
17th Apr 20125:34 pmRNSAnnual Financial Report
6th Mar 20127:00 amRNS2011 Preliminary Results
27th Feb 20127:00 amRNSNotice of Preliminary Results
9th Jan 20127:00 amRNSNon-Executive Director Appointment
21st Dec 201110:10 amRNSAccident at Gainesville R&D Site
1st Nov 201112:01 pmRNSPurchase Order Update
1st Nov 20117:00 amRNSPurchase Order and Business Update
27th Sep 20117:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.